{"id":52534,"date":"2023-01-04T17:03:02","date_gmt":"2023-01-04T16:03:02","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/verge-genomics-to-present-at-41st-annual-j-p-morgan-healthcare-conference-on-january-12-2023\/"},"modified":"2023-01-04T17:03:02","modified_gmt":"2023-01-04T16:03:02","slug":"verge-genomics-to-present-at-41st-annual-j-p-morgan-healthcare-conference-on-january-12-2023","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/verge-genomics-to-present-at-41st-annual-j-p-morgan-healthcare-conference-on-january-12-2023\/","title":{"rendered":"Verge Genomics to Present at 41st Annual J.P. Morgan Healthcare Conference on January 12, 2023"},"content":{"rendered":"
\n

SAN FRANCISCO–(BUSINESS WIRE)–#JPM2023<\/a>–Verge Genomics, a clinical-stage, tech-enabled biotechnology company pioneering the use of artificial intelligence (AI) and human data to transform drug discovery, announced that Alice Zhang, CEO and co-founder of Verge Genomics, will present at the 41st<\/sup> Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2023 at 11:30 AM (PT).\n<\/p>\n

<\/a><\/p>\n

\nOnsite:<\/b>\n<\/p>\n

\nPresentation<\/b>: Thursday, January 12
\n
Where<\/b>: Mission Bay (32nd floor), The Westin St. Francis, San Francisco
\n
Time<\/b>: 11:30 AM – 11:55 AM (PT)
\n
Presenter<\/b>: Alice Zhang, CEO and co-founder, Verge Genomics\n<\/p>\n

\nAbout Verge Genomics<\/b>\n<\/p>\n

\nVerge uses AI and human data to develop better drugs faster for the most challenging diseases of our generation. Verge has built CONVERGE\u2122, an end-to-end drug discovery and development platform, that integrates multiple technological innovations from discovery to translation to streamline drug development. Its pioneering use of the industry\u2019s most advanced all-in-human, AI-powered drug discovery platform identifies new medicines more efficiently and with an improved probability of success.\n<\/p>\n

\nVerge is one of the first AI-enabled drug discovery companies to independently develop a clinical candidate from a novel target discovered from its platform. Verge has further demonstrated the power of CONVERGE\u2122 by delivering a broad pipeline spanning diverse therapeutic areas, with its first program, an investigational PIKfyve inhibitor for the treatment of ALS, now in the clinic. The company is led by experienced drug developers and computational biologists with a shared belief that technology has created a new opportunity to deliver life-changing medicines more efficiently.\n<\/p>\n

\nFor additional information, please visit VergeGenomics.com<\/a>. Follow us on LinkedIn<\/a> and Twitter<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nVerge Genomics
\n
Adam Silverstein
\n
Scient PR
\n
adam@scientpr.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SAN FRANCISCO–(BUSINESS WIRE)–#JPM2023–Verge Genomics, a clinical-stage, tech-enabled biotechnology company pioneering the use of artificial intelligence (AI) and human data to transform drug discovery, announced that Alice Zhang, CEO and co-founder of Verge Genomics, will present at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2023 at 11:30 AM (PT). Onsite: Presentation: Thursday, … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-52534","6":"format-standard","7":"category-industry"},"yoast_head":"\nVerge Genomics to Present at 41st Annual J.P. Morgan Healthcare Conference on January 12, 2023 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/verge-genomics-to-present-at-41st-annual-j-p-morgan-healthcare-conference-on-january-12-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Verge Genomics to Present at 41st Annual J.P. Morgan Healthcare Conference on January 12, 2023 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SAN FRANCISCO–(BUSINESS WIRE)–#JPM2023–Verge Genomics, a clinical-stage, tech-enabled biotechnology company pioneering the use of artificial intelligence (AI) and human data to transform drug discovery, announced that Alice Zhang, CEO and co-founder of Verge Genomics, will present at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2023 at 11:30 AM (PT). Onsite: Presentation: Thursday, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/verge-genomics-to-present-at-41st-annual-j-p-morgan-healthcare-conference-on-january-12-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-04T16:03:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230104005657\/en\/1676671\/21\/Verge_Logo_%286%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verge-genomics-to-present-at-41st-annual-j-p-morgan-healthcare-conference-on-january-12-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verge-genomics-to-present-at-41st-annual-j-p-morgan-healthcare-conference-on-january-12-2023\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Verge Genomics to Present at 41st Annual J.P. Morgan Healthcare Conference on January 12, 2023\",\"datePublished\":\"2023-01-04T16:03:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verge-genomics-to-present-at-41st-annual-j-p-morgan-healthcare-conference-on-january-12-2023\\\/\"},\"wordCount\":277,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verge-genomics-to-present-at-41st-annual-j-p-morgan-healthcare-conference-on-january-12-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230104005657\\\/en\\\/1676671\\\/21\\\/Verge_Logo_%286%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verge-genomics-to-present-at-41st-annual-j-p-morgan-healthcare-conference-on-january-12-2023\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verge-genomics-to-present-at-41st-annual-j-p-morgan-healthcare-conference-on-january-12-2023\\\/\",\"name\":\"Verge Genomics to Present at 41st Annual J.P. Morgan Healthcare Conference on January 12, 2023 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verge-genomics-to-present-at-41st-annual-j-p-morgan-healthcare-conference-on-january-12-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verge-genomics-to-present-at-41st-annual-j-p-morgan-healthcare-conference-on-january-12-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230104005657\\\/en\\\/1676671\\\/21\\\/Verge_Logo_%286%29.jpg\",\"datePublished\":\"2023-01-04T16:03:02+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verge-genomics-to-present-at-41st-annual-j-p-morgan-healthcare-conference-on-january-12-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verge-genomics-to-present-at-41st-annual-j-p-morgan-healthcare-conference-on-january-12-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verge-genomics-to-present-at-41st-annual-j-p-morgan-healthcare-conference-on-january-12-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230104005657\\\/en\\\/1676671\\\/21\\\/Verge_Logo_%286%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230104005657\\\/en\\\/1676671\\\/21\\\/Verge_Logo_%286%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/verge-genomics-to-present-at-41st-annual-j-p-morgan-healthcare-conference-on-january-12-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Verge Genomics to Present at 41st Annual J.P. Morgan Healthcare Conference on January 12, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Verge Genomics to Present at 41st Annual J.P. Morgan Healthcare Conference on January 12, 2023 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/verge-genomics-to-present-at-41st-annual-j-p-morgan-healthcare-conference-on-january-12-2023\/","og_locale":"en_US","og_type":"article","og_title":"Verge Genomics to Present at 41st Annual J.P. Morgan Healthcare Conference on January 12, 2023 - Pharma Trend","og_description":"SAN FRANCISCO–(BUSINESS WIRE)–#JPM2023–Verge Genomics, a clinical-stage, tech-enabled biotechnology company pioneering the use of artificial intelligence (AI) and human data to transform drug discovery, announced that Alice Zhang, CEO and co-founder of Verge Genomics, will present at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2023 at 11:30 AM (PT). Onsite: Presentation: Thursday, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/verge-genomics-to-present-at-41st-annual-j-p-morgan-healthcare-conference-on-january-12-2023\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-04T16:03:02+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230104005657\/en\/1676671\/21\/Verge_Logo_%286%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/verge-genomics-to-present-at-41st-annual-j-p-morgan-healthcare-conference-on-january-12-2023\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/verge-genomics-to-present-at-41st-annual-j-p-morgan-healthcare-conference-on-january-12-2023\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Verge Genomics to Present at 41st Annual J.P. Morgan Healthcare Conference on January 12, 2023","datePublished":"2023-01-04T16:03:02+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/verge-genomics-to-present-at-41st-annual-j-p-morgan-healthcare-conference-on-january-12-2023\/"},"wordCount":277,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/verge-genomics-to-present-at-41st-annual-j-p-morgan-healthcare-conference-on-january-12-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230104005657\/en\/1676671\/21\/Verge_Logo_%286%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/verge-genomics-to-present-at-41st-annual-j-p-morgan-healthcare-conference-on-january-12-2023\/","url":"https:\/\/pharma-trend.com\/en\/verge-genomics-to-present-at-41st-annual-j-p-morgan-healthcare-conference-on-january-12-2023\/","name":"Verge Genomics to Present at 41st Annual J.P. Morgan Healthcare Conference on January 12, 2023 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/verge-genomics-to-present-at-41st-annual-j-p-morgan-healthcare-conference-on-january-12-2023\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/verge-genomics-to-present-at-41st-annual-j-p-morgan-healthcare-conference-on-january-12-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230104005657\/en\/1676671\/21\/Verge_Logo_%286%29.jpg","datePublished":"2023-01-04T16:03:02+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/verge-genomics-to-present-at-41st-annual-j-p-morgan-healthcare-conference-on-january-12-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/verge-genomics-to-present-at-41st-annual-j-p-morgan-healthcare-conference-on-january-12-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/verge-genomics-to-present-at-41st-annual-j-p-morgan-healthcare-conference-on-january-12-2023\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230104005657\/en\/1676671\/21\/Verge_Logo_%286%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230104005657\/en\/1676671\/21\/Verge_Logo_%286%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/verge-genomics-to-present-at-41st-annual-j-p-morgan-healthcare-conference-on-january-12-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Verge Genomics to Present at 41st Annual J.P. Morgan Healthcare Conference on January 12, 2023"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52534","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52534"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52534\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52534"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52534"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52534"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}